Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Richard Silver is Professor of Medicine, Attending Physician and Emeritus Director of the Richard T. Silver M.D. Myeloproliferative Neoplasm Center at New York Presbyterian-Weill Cornell Medical Center. He is also Medical Director of the The Cancer Research and Treatment Fund, Inc.; past President and current Member of the Board of Directors, New York State Society of Medical Oncologists and Hematologists; past President and currently Senior Advisor, Weill Cornell Medical College, Alumni Association, Life Member, Cornell University Council. Dr. Silver’s current interests are in developmental therapeutics and evaluating small molecular drugs for treating chronic myeloid leukemia and the myleoproliferative neoplasms, polycythemia vera, essential thrombocythemia and primary myelofibrosis. He is currently the Principal Investigator at Weill Cornell Medical Center of the Myeloproliferative Research Consortium, an RO1 NIH grant on the treatment of myleoproliferative neoplasms, and served as Chairman of its Membership Committee and on its Executive Committee.